Angkawinitwong, U;
Courtenay, AJ;
Rodgers, A;
Larraneta, E;
McCarthy, HO;
Brocchini, S;
Donnelly, RF;
(2020)
A novel transdermal protein delivery strategy via electrohydrodynamic coating of PLGA microparticles onto microneedles.
ACS Applied Materials & Interfaces
, 12
(11)
pp. 12478-12488.
10.1021/acsami.9b22425.
Preview |
Text
Williams_2020214 OVA coated MNs paper ACS AMI R2 no tracks.pdf - Accepted Version Download (1MB) | Preview |
Abstract
Transdermal delivery of biological therapeutics is emerging as a potent alternative to intravenous or subcutaneous injections. The latter come with major challenges including patient discomfort, the necessity for trained personnel, specialized sharps disposal, and risk of infection. Microneedle (MN) technology circumvents many of the abovementioned challenges, delivering biological material directly into the skin and allowing sustained release of the active ingredient both in animal models and in humans. This study describes the use of electrohydrodynamic atomization (EHDA) to coat ovalbumin (OVA)-encapsulated PLGA nanoparticles onto hydrogel-forming MN arrays. The particles showed extended release of OVA over ca. 28 days. Microscopic analysis demonstrated that EHDA could generate a uniform particle coating on the MNs, with 30% coating efficiency. Furthermore, the coated MN array manifested similar mechanical characteristics and insertion properties to the uncoated system, suggesting the coating should have no detrimental effects on the application of the MNs. The coated MNs resulted in no significance increase in anti-OVA specific IgG titres in C57BL/6 mice in vivo as compared to the untreated mice (paired t-test, p >0.05) indicating that the formulations are non-immunogenic. The approach of using EHDA to coat a MN array thus appears to have potential as a novel non-invasive protein delivery strategy.
| Type: | Article |
|---|---|
| Title: | A novel transdermal protein delivery strategy via electrohydrodynamic coating of PLGA microparticles onto microneedles |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1021/acsami.9b22425 |
| Publisher version: | https://doi.org/10.1021/acsami.9b22425 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy > Pharmaceutics |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10091585 |
Archive Staff Only
 |
View Item |
